The Glycomic MS Database and Repository

Announcement date

2026/04/10

Responsible:

Richard D Cummings . Department of Surgery, Division of Surgical Sciences, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, United States

Description

Studies on N-glycans of human glycoproteins is hampered by the lack of standards that reflect the wide diversity in composition and branching typically observed. To this end we have exploited a large library of N-glycan standards comprised of a unique collection of 186 N-glycans including oligomannose, hybrid, and complex-type. We generated a targeted method employing porous graphitized carbon (PGC) and liquid chromatography mass spectrometry (PGC-LC-MS), which can provide a high degree of resolution of unmodified N-glycans as well as separation of structural isomers. Chromatogram libraries arising from these studies include retention time data, diagnostic fragment ions, and validated structural assignments, providing a robust platform for both targeted and discovery-based glycomics. We refer to this as an N-glycopedia, the first type of resource in which researchers can compare this collective data to N-glycans under study from natural sources and overcome the limitations of only having compositional data and predicted structures. The technology is easily expandable to include additional N-glycans as new standards become available.

Sample preparation


1. Sample Origin

General information:
Novel data acquisition method involving glycan release, optional permethylation, clean-up, and acquisition by MS.


1.1 Biologically derived material

Biologically derived material - Recombinantly produced material

Cell type:
Expi-CHO

Growth/harvest conditions for recombinantly produced material:
Cell lines (Pro5, Lec2, and Lec8) were grown according to the supplier's instructions, in media supplemented with 10% fetal bovine serum. Six cell culture replicates were grown to approximately a 50% density in 6-well plate and allowed to grow for 24–48 h at 37°C until confluent (∼105 cells per well). The medium was aspirated and each well was washed four to five times with PBS. The cell pellets were collected and frozen for downstream preparation. Frozen cells were lysed in 10% SDS via probe sonication (3x 10 seconds on, 10 seconds off)


Biologically derived material - Biological origin of Material

Origin (biological fluid, tissue, etc):
N/A

Species:
N/A

Treatments and/or storage conditions:
N/A

Glycoprotein:
N/A


Biologically derived material - Purchased from commercial manufacturer

Vendor and applicable item information:
Human immunoglobulins (IgG, IgM, IgA) were purchased from Athens Research & Technology (https://www.athensresearch.com). SARS-CoV2 spike proteins were produced and sourced from BEI. Purified glycoproteins for initial profiling were purchased from Sigma Aldrich.


1.2 Chemically derived material

Synthesis steps or specify where the equivalent reaction protocol is available:
N-glycan standards were sourced from five vendors (Dextra Laboratories Ltd, Omicron Biochemicals Inc., Glycobia Inc., Chemily LLC, and Cassia LLC). Fresh standards were made up to approximately 50 pmol/µL with ultrapure water with 0.1% piperidine.

Description of starting material:
Free-Oligosaccharides


2. Sample Processing

2.1 Sample Processing - Isolation

Enzymatic treatments

Enzymes used for oligosaccharide removal or modification of starting material:
Release method-PNGaseF TREATMENT

Describe vendor or expression and purification procedure:
NEB

Sample material treated in-solution or immobilized? State also temperature, duration, volume, enzyme concentration:
60 µL of PNGase-F digestion solution was added (New England Biolabs, 1 unit, H2O) and incubated at 37 °C for 18 hours.


Chemical treatments

Define the technique for oligosaccharide release or other chemical modifications:
N/A

Reaction conditions (temperature, duration, volume and chemical concentrations):
N/A


2.2 Sample Processing - Modification

Enzymatic modifications

Describe any treatments made to the isolated material:
N/A

Enzyme concentration, supplier, biological source, incubation time and temperature:
N/A

If novel glycosidase was used, provide information indicating the origin (i.e. species) of the enzyme:
N/A


Chemical modifications

Describe any treatments made to the isolated material:
N/A

Explain the type of modification employed:
N/A

Source of materials, description of kits used, reaction conditions and detailed workflow:
N/A


2.3 Sample Processing - Purification

Purification steps:
Carbon clean was performed as per manufacturer’s protocol (Hypercarb 25 mg x 96 well plate, Thermo Fisher), which includes loading glycan (0.1% TFA), washing out salts (0.1% TFA), eluting the glycans (50% acetonitrile, 0.1% TFA), and drying down in a 96 well plate.


3. Defined Sample

Sample name:
N-linked oligosaccharides




Liquid chromatography


1. Equipment

Manufacturer:
Thermo Fisher

Model:
Vanquish

Instrument details:
Thermofisher Scientific Vanquish Horizon HPLC with MP35N fittings and Vipers.


1.1 Column details & characteristics

Manufacturer:
Thermo Fisher

Model:
Hypercarb

Separation Mode:
Reversed phase

Column length:
100 mm

Inner diameter:
1 mm

Total volume (if relevant):
N/A

Stationary Phase:
PGC 3 micron pore size

Column heater:
Vanquish

Additional accessories:
N/A


1.2 Mobile phase

Description of solvent:
Both mobile phases contained 5 mM HFIP and 5 mM butylamine, with mobile phase A composed of water and mobile phase B composed of 40% water and 60% acetone. LC separation was performed at 155 µL/min.

Description of constituents:
N/A


1.3 Properties of the chromatographic run (parameters that may change over run time)

Time:
20 - 80 min

Gradient:
The final gradient used for glycans released from protein was 0-37% mobile phase B over 70 min, held at 99% B for 5 min, then held at 0% B for 5 min.

Flow rate:
155 ul/min

Temperature:
70 C


Sample injection procedure

Volume:
3-10

Buffer:
H2O

Inline/offline:
Inline

Direct/loop (full/partial loop):
Partial loop

Flush conditions:
Loop kept inline for gradient

Sample storage temperature:
4 oC

Sample loop material:
Stainless steel

Type of sample vials used:
96 well plate


1.4 Pre- and post run processes

(a) Pre-run process

Type:
Dextran ladder

Substance, standards:
Dextran ladder

Time:
3 injections

Flow rate:
155 ul/min

Type of gradient mixer:
Binary

Post separation events:
Directly into an MS

Column regeneration:
N/A

Equipment used for detection:
MS

Detector type:
MS

Detection system:
MS


Equipment settings

Wavelength(s):
N/A

Gain:
N/A

Frequency that is being detected:
N/A

Sampling frequency (e.g. 10 Hz):
N/A

Timescale over which data was collected:
20-80 min.


(b) Post-run process

Type:
Dextran ladder

Substance, standards:
Dextran ladder

Time:
3 injections

Flow rate:
155 ul/min

Type of gradient mixer:
Binary

Post separation events:
Directly into an MS

Column regeneration:
N/A

Equipment used for detection:
MS

Detector type:
MS

Detection system:
MS


Equipment settings

Wavelength(s):
N/A

Gain:
N/A

Frequency that is being detected:
N/A

Sampling frequency (e.g. 10 Hz):
N/A

Timescale over which data was collected:
N/A


1.5 Column outputs - fractions (if separation purpose is preparative)

Fraction name:
N/A


(a) Description of the procedure by which the fractions were collected

Start time:
N/A

End time:
N/A

Mode (fixed or peak directed):
N/A


(b) Description of the individual fractions

Time of collection:
N/A

Volume:
N/A

Charge:
N/A

Flow split:
N/A

LC-MALDI spotting:
N/A


1.6 Data annotation

Database name:
Glycostore

Database version:
July 24, 2024

Software name:
Skyline

Software version:
25.0

Software URL:
skyline.ms

Peak selection:
Informed based on isotopes and manual integration

Peak quantitation:
Subtraction from noise, trapezoidal intergration

Trace output:
Skyline Assays


2. Exoglycosidase treatment

Supplier name:
N/A

Exoglycosidase preparation (ref to sample prep):
N/A

Reaction time (ref to sample prep):
N/A

Control:
N/A

Protocol:
N/A



MS


1. General features

(a) Global descriptors

Instrument manufacturer:
Thermo Fisher

Instrument model:
TSQ Altis Plus

Customizations:
N/A

Ion mode:
Negative


(b) Control and analysis software

Software name:
Xcalibur

Version:
4.6

Upgrades not reflected in version number:
N/A

Switching criteria (tandem only):
N/A

Isolation width (global, or by MS level):
2

Location of ‘parameters’ file:
Raw files, freely viewed by Freestyle


2. Ion sources

(a) Electrospray Ionisation (ESI)

Supply type (static, or fed):
LC

Interface name:
N/A

Catalog number, vendor, and any modifications made to the standard specification:
N/A

Sprayer name:
N/A

Sprayer type, coating, manufacturer, model and catalog number (where available):
N/A

Relevant voltages where appropriate (tip, cone, acceleration):
N/A

Degree of prompt fragmentation evaluated:
Yes

Whether in-source dissociation performed:
No

Other parameters if discriminant for the experiment (such as nebulizing gas and pressure):
Sheath gas at 20 arbitrary units


(b) MALDI

Plate composition (or type):
N/A

Matrix composition (if applicable):
N/A

Deposition technique:
N/A

Relevant voltages where appropriate:
N/A

Degree of prompt fragmentation evaluated:
N/A

PSD (or LID/ISD) summary, if performed:
N/A

Operation with or without delayed extraction:
N/A

Laser type (e.g., nitrogen) and wavelength (nm):
N/A

Other laser related parameters, if discriminating for the experiment:
N/A


3. Ion transfer optics

Hardware options:
N/A


(a) Post-source componentry - Collision cell

Collision-Induced Dissociation (CID)

Gas composition:
Argon

Gas pressure:
N/A

Collision energy CID/function:
Varying CE, but beam-type


Electron Transfer Dissociation (ETD)

Reagent gas:
N/A

Pressure:
N/A

Reaction time:
N/A

Number of reagent atoms:
N/A


Electron Capture Dissociation (ECD)

Emitter type:
N/A

Voltage:
N/A

Current:
N/A


(b) Post-source componentry - TOF drift tube

Reflectron status (on, off, none):
None


(c) Post-source componentry - Ion trap

Final MS stage achieved:
2


(d) Post-source componentry - Ion mobility

Gas:
N/A

Pressure:
N/A

Instrument-specific parameters:
N/A


(e) Post-source componentry - FT-ICR

Peak selection:
N/A

Pulse:
N/A

Width:
N/A

Voltage:
N/A

Decay time:
N/A

IR:
N/A

Other parameters:
N/A


(f) Post-source componentry - Detectors

Detector type:
Quadrupole with Electron Multiplier